Article Detail - JE Part B

Date Posted: February 5, 2026

This Billing and Coding Article has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Effective Date: July 2, 2024

Summary of Changes:

Under Article Text revised Table 2 APOE row to add donanemab. This revision is due to FDA guidelines and is effective 7/2/2024.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.